• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » The view from HRS 2014: This week at the Heart Rhythm Society’s 35th Annual Scientific Sessions

The view from HRS 2014: This week at the Heart Rhythm Society’s 35th Annual Scientific Sessions

May 7, 2014 By Arezu Sarvestani

The view from HRS 2014:

Things are still pretty quiet on opening day of Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions in semi-sunny San Francisco, but the week is shaping up to be a busy one.

There are few major announcements expected from this year’s sessions, but attendees are looking forward to some important updates on key new technologies and trends in cardiac pacing and electrophysiology, coming from the biggest players in the market.

Here are some of the things that MassDevice.com is keeping an eye out for this year:

Medtronic’s tiny cardiac monitor

Industry giant Medtronic (NYSE:MDT) is on site in force, showing off its Reveal LINQ insertable cardiac monitor, which won CE Mark approval in the European Union earlier this year.

The Reveal monitor uses the Carelink network to allow physicians to monitor patients from afar. The device is "80% smaller than other ICMs" with a profile about one-third the size of an AAA battery.

The team has also been active on Twitter as it set up its massive booth and hosted a series of courses, sessions and events.

Lead-free pacing

Boston Scientific (NYSE:BSX) and St. Jude Medical (NYSE:STJ) are vying to tout their lead-free implantable cardioverter defibrillators, and both are revealing new clinical data to support their devices.

Boston Scientific is hosting a pair of talks about its S-ICD device, including 22-month data from its an IDE trial ("Outcomes in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD): IDE Trial Results at 22 Months," 5/8, 1:30 p.m. in Room 2018, Moscone West) and a poster session about complications associated with implants ("Complications Associated with the Totally Subcutaneous Implantable Defibrillator: Overview of results from a pooled analysis of 882 S-ICD System patients from the IDE Study and EFFORTLESS Registry in this poster presentation," 5/7, P001-53 at 6:00 p.m. in the Exhibit Hall).

St. Jude’s Nanostim is among this year’s late-breaking clinical trial sessions, with new data on a 1-year follow-up from the company’s LEADLESS trial ("Chronic Performance of Leadless Cardiac Pacing: One Year Follow-up to the LEADLESS Trial," 5/9 at 8 a.m., Room 305, Moscone South).

St. Jude updates on problem leads

St. Jude Medical is also the subject of a series of sessions about its defibrillator leads, which were the subject of a major flap in 2012 after the Heart Rhythm Society published a study attributing 22 deaths to short circuits in St. Jude’s Riata defibrillator leads.

St. Jude called for a retraction of the study and accused its rivals of advancing a "whisper campaign" to bring down other St. Jude leads.

The company spent some time at last year’s conference touting independent safety data for its next-generation Durata leads and calming speculation about its recalled recalled QuickSite and QuickFlex cardiac rhythm therapy leads.

This year’s HRS roster features sessions defending Durata ("Absence of Externalized Conductors and Electrical Dysfunction in Systematically Imaged Durata ICD Leads," 5/10 at 9:30 a.m. in the Exhibit Hall), discussing problems with the Riata and Riata ST leads ("Incidence of New Externalized Conductors and Electrical Dysfunction in Riata and Riata ST Silicone ICD Leads," 5/08 at 1:45 p.m. in Rm 2010, Moscone West) and exploring potential failures in leads coated with Optim, an insulation material that St. Jude has touted as more durable than the coating on its troubled Riata leads ("Optim ICD Lead Failures: Long-term Rates from Independent Analysis of 11,016 Leads in 3 Prospective Registries," Poster session PO05-52; 5/9 at 3:30 p.m.)

HRS talks cybersecurity

Concerns about the digital vulnerabilities of medical devices have made their way to HRS, with a single session dedicated to exploring cybersecurity ("Are Devices Secure Against Internet Hackers: Cybersecurity? Perspectives from: AAMI/Industry," 5/8 at 4:30 p.m. in Room 206, Moscone North).

The battle for battery life

Another year brings another battle over device longevity. Boston Scientific won the battle last year, touting longer battery life with its cardiac resynchronization therapy defibrillators compared to rival devices from Medtronic. A new independent study coming out this week will again pit rival devices against one another ("Device Longevity in Cardiac Resynchronization Therapy Implantable Cardioverter Defibrillators Differs Between Manufacturers," 5/8 at 9:30 a.m. in the Exhibit Hall).

Filed Under: News Well Tagged With: Cardiac Rhythm Management, Conference coverage, Heart Rhythm Society, HRS 2014

In case you missed it

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Dyad Medical wins FDA clearance for cardiac imaging platform Echo:Prio
  • Outset Medical wins national VA contract
  • Inspire Medical Systems appoints former Zimmer Biomet exec as VP of investor relations
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
  • ResMed expects steady growth over the next year
  • Ambu is letting go of 200 employees
  • Medtronic has Class I recall for low-shock risk in ICDs
  • Titan Medical to start manufacturing Enos systems later this year
  • ZimVie sales down more than 11% in Q2 as it streamlines after spinoff
  • Cardinal Health’s CFO to move up to corner office
  • Levita Magnetics raises $26M for Magnetic-Assisted Robotic Surgery platform
  • Data supports use of Channel Medsystems Cerene cryotherapy
  • The 10 largest orthopedic device companies in the world
  • Nanopath raises $10M Series A for women’s health diagnostics
  • Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy

RSS From Medical Design & Outsourcing

  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy